We are pleased to announce that we have launched Fluorouracil Injection, USP 5 g per 100 mL, NDC 71288-154-76, in a pack of 1 PBP vial.
This is in addition to the Fluorouracil Injection, USP 2.5 g per 50 mL, NDC 71288-170-75 PBP Vial already available in the market since November 2024.
ABOUT FLUOROURACIL INJECTION
Fluorouracil Injection is a nucleoside metabolic inhibitor indicated for the treatment of patients with
- Adenocarcinoma of the Colon and Rectum
- Adenocarcinoma of the Breast
- Gastric Adenocarcinoma
- Pancreatic Adenocarcinoma
For full prescribing and safety information, please click on the following links.
- For Fluorouracil Injection, USP 2.5 g per 50 mL, click this link.
- For Fluorouracil Injection, USP 5 g per 100 mL, click this link.
Learn more about Fluorouracil Injection, USP.
